PASSERI DANIEL R
- SEC CIK
- 0001190121
Latest role at each company
- CUE Cue Biopharma, Inc.CHIEF EXECUTIVE OFFICERas of Mar 25, 2025
Trades
Every Form 4 that lists PASSERI DANIEL R as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| CUECue Biopharma, Inc. | Dec 18, 2024 | Dec 16, 2024 | PASSERI DANIEL RCHIEF EXECUTIVE OFFICER | PPurchaseCommon Stock | +30K | $1.03 | +$30.9K | 164.58K | +22.3% | SEC |
| CUECue Biopharma, Inc. | Aug 16, 2023 | Aug 14, 2023 | PASSERI DANIEL RCHIEF EXECUTIVE OFFICER | PPurchaseCommon Stock | +3K | $2.86 | +$8.58K | 134.58K | +2.3% | SEC |
| CUECue Biopharma, Inc. | Sep 27, 2021 | Sep 24, 2021 | PASSERI DANIEL RCHIEF EXECUTIVE OFFICER | PPurchaseCommon Stock | +3.4K | $14.72 | +$50.05K | 55.38K | +6.5% | SEC |